Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate

The effect of bezafibrate on serum lipids, lipoproteins and the apoproteins A-I, A-II and B was studied in 18 patients with primary hypercholesterolaemia. Total cholesterol was lowered by 20% ( P < 0.05), LDL-cholesterol by 24% ( P < 0.05), and apo B by 14% ( P < 0.05), which is comparable...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Atherosclerosis 1981-10, Vol.40 (2), p.153-158
Hauptverfasser:	Mordasini, R., Riesen, W., Oster, P., Keller, M., Middelhoff, G., Lang, P.D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Apolipoprotein A-I Apolipoprotein A-II Apolipoproteins - blood Apolipoproteins B Apoprotein AI Apoprotein AII Bezafibrate Cholesterol - blood Cholesterol, HDL Cholesterol, LDL Clofibrate - analogs & derivatives Clofibric Acid - analogs & derivatives Clofibric Acid - therapeutic use Female HDL-cholesterol Humans Hypercholesterolemia - blood Hypercholesterolemia - drug therapy Hypolipidemic Agents - therapeutic use Lipoproteins, HDL - blood Lipoproteins, LDL - blood Lipoproteins, VLDL - blood Male Middle Aged Triglycerides - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!